These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 26345938)

  • 1. Effects of microwave ablation or its combination with whole-body chemotherapy on serum vascular endothelial growth factor levels in patients with stage IIIB/IV NSCLC.
    Sun YH; Song PY; Guo Y; Pang M; He WN; Zhang WH; Sheng LJ
    Genet Mol Res; 2015 Aug; 14(3):10015-25. PubMed ID: 26345938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microwave ablation plus chemotherapy improved progression-free survival of advanced non-small cell lung cancer compared to chemotherapy alone.
    Wei Z; Ye X; Yang X; Huang G; Li W; Wang J; Han X
    Med Oncol; 2015 Feb; 32(2):464. PubMed ID: 25572816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum vascular endothelial growth factor (VEGF) and bcl-2 levels in advanced stage non-small cell lung cancer.
    Tas F; Duranyildiz D; Oguz H; Camlica H; Yasasever V; Topuz E
    Cancer Invest; 2006 Oct; 24(6):576-80. PubMed ID: 16982461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating serum vascular endothelial growth factor is not a prognostic factor of non-small cell lung cancer.
    Chakra M; Pujol JL; Lamy PJ; Bozonnat MC; Quantin X; Jacot W; Daurès JP
    J Thorac Oncol; 2008 Oct; 3(10):1119-26. PubMed ID: 18827607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive role of plasma vascular endothelial growth factor for the effect of celecoxib in advanced non-small cell lung cancer treated with chemotherapy.
    Sörenson S; Fohlin H; Lindgren A; Lindskog M; Bergman B; Sederholm C; Ek L; Lamberg K; Clinchy B
    Eur J Cancer; 2013 Jan; 49(1):115-20. PubMed ID: 22951014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized study comparing the effectiveness of microwave ablation radioimmunotherapy and postoperative adjuvant chemoradiation in the treatment of non-small cell lung cancer.
    Zhao Z; Su Z; Zhang W; Luo M; Wang H; Huang L
    J BUON; 2016; 21(2):326-32. PubMed ID: 27273941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Local microwave ablation with continued EGFR tyrosine kinase inhibitor as a treatment strategy in advanced non-small cell lung cancers that developed extra-central nervous system oligoprogressive disease during EGFR tyrosine kinase inhibitor treatment: A pilot study.
    Ni Y; Bi J; Ye X; Fan W; Yu G; Yang X; Huang G; Li W; Wang J; Han X; Ni X; Wei Z; Han M; Zheng A; Meng M; Xue G; Zhang L; Wan C
    Medicine (Baltimore); 2016 Jun; 95(25):e3998. PubMed ID: 27336903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival of patients with advanced non-small-cell lung cancer at Ubon Ratchathani Cancer Center, Thailand.
    Srisam-Ang K; Podhipak A; Narksawat K; Supaattagorn P; Tipayamongkholgul M
    Southeast Asian J Trop Med Public Health; 2005 Jul; 36(4):994-1006. PubMed ID: 16295558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined VEGF-A and VEGFR-2 concentrations in plasma: diagnostic and prognostic implications in patients with advanced NSCLC.
    Jantus-Lewintre E; Sanmartín E; Sirera R; Blasco A; Sanchez JJ; Tarón M; Rosell R; Camps C
    Lung Cancer; 2011 Nov; 74(2):326-31. PubMed ID: 21481963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined Ang-2 and VEGF serum levels: holding hands as a new integral biomarker in non-small-cell lung cancers.
    Coelho AL; Araújo AM; Gomes MP; Catarino RJ; Andrade EB; Lopes AM; Medeiros RM
    Future Oncol; 2015; 11(24):3233-42. PubMed ID: 26562248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advanced non small cell lung cancer: response to microwave ablation and EGFR Status.
    Wei Z; Ye X; Yang X; Huang G; Li W; Wang J; Han X; Meng M; Ni Y
    Eur Radiol; 2017 Apr; 27(4):1685-1694. PubMed ID: 27436020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular endothelial growth factor, p53, Rb, Bcl-2 expression and response to chemotherapy in advanced non-small cell lung cancer.
    Ludovini V; Gregorc V; Pistola L; Mihaylova Z; Floriani I; Darwish S; Stracci F; Tofanetti FR; Ferraldeschi M; Di Carlo L; Ragusa M; Daddi G; Tonato M
    Lung Cancer; 2004 Oct; 46(1):77-85. PubMed ID: 15364135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum levels of HMGB1, survivin, and VEGF in patients with advanced non-small cell lung cancer during chemotherapy.
    Naumnik W; Nilklińska W; Ossolińska M; Chyczewska E
    Folia Histochem Cytobiol; 2009; 47(4):703-9. PubMed ID: 20430742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum levels of VEGF-C, VEGF-D, and sVEGF-R2 in patients with lung cancer during chemotherapy.
    Naumnik W; Izycki T; Swidzińska E; Ossolińiska M; Chyczewska E
    Oncol Res; 2007; 16(9):445-51. PubMed ID: 18074680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salvage treatment of NSCLC recurrence after first-line chemotherapy failure: Iodine-125 seed brachytherapy or microwave ablation?
    Liu B; Wang Y; Tian S; Hertzanu Y; Zhao X; Li Y
    Thorac Cancer; 2020 Mar; 11(3):697-703. PubMed ID: 31995853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and clinical outcomes of computed tomography-guided percutaneous microwave ablation in patients aged 80 years and older with early-stage non-small cell lung cancer: A multicenter retrospective study.
    Han X; Yang X; Huang G; Li C; Zhang L; Qiao Y; Wang C; Dong Y; Chen X; Feng Q; Wang C; Rong Z; Ding K; Wei Z; Ni Y; Wang J; Li W; Meng M; Ye X
    Thorac Cancer; 2019 Dec; 10(12):2236-2242. PubMed ID: 31679181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum angiopoietin-2 as a clinical marker for lung cancer.
    Park JH; Park KJ; Kim YS; Sheen SS; Lee KS; Lee HN; Oh YJ; Hwang SC
    Chest; 2007 Jul; 132(1):200-6. PubMed ID: 17505039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microwave ablation combined with chemotherapy improved progression free survival of IV stage lung adenocarcinoma patients compared with chemotherapy alone.
    Li C; Wang J; Shao JB; Zhu LM; Sun ZG; Zhang N
    Thorac Cancer; 2019 Jul; 10(7):1628-1635. PubMed ID: 31243894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results of trimodality therapy in patients with stage IIIA (N2-bulky) and stage IIIB non-small-cell lung cancer.
    Li J; Dai CH; Yu LC; Chen P; Li XQ; Shi SB; Wu JR
    Clin Lung Cancer; 2009 Sep; 10(5):353-9. PubMed ID: 19808194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is microwave ablation an alternative to stereotactic ablative body radiotherapy in patients with inoperable early-stage primary lung cancer?
    Watson RA; Tol I; Gunawardana S; Tsakok MT
    Interact Cardiovasc Thorac Surg; 2019 Oct; 29(4):539-543. PubMed ID: 31157860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.